HC Wainwright Reduces Earnings Estimates for Prime Medicine
Investment analysts at HC Wainwright decreased their FY2024 earnings per share (EPS) estimates for Prime Medicine in a ...
Prime Medicine, Inc. (PRME) Gets a Hold from Morgan Stanley
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Prime Medicine, Inc. (PRME – Research Report), ...
Business Insider5d
Prime Medicine, Inc. Receives Buy Rating from Arthur He CFA: Strategic Partnerships and Pipeline Focus Drive Promising Future Prospects
H.C. Wainwright analyst Arthur He CFA maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report) today and set a price target of $10.00. Arthur He CFA has given his Buy rating due to a ...
Yahoo Finance4d
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?
So, the natural question for Prime Medicine (NASDAQ:PRME) shareholders is whether they should be concerned by its rate of cash burn. For the purposes of this article, cash burn is the annual rate ...
Yahoo Finance12d
Prime Medicine to Participate in Upcoming Investor Conferences
Prime Medicine, Inc. CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...
Nasdaq11d
Prime Medicine to Participate in Upcoming Investor Conferences
Replays of each webcast will be available on the Prime Medicine website for 90 days following the event. Prime Medicine is a leading biotechnology company dedicated to creating and delivering the ...
bovnews6d
What’s Fueling Prime Medicine Inc (PRME) Stock’s -21.64% Loss Below Its 200-Day SMA?
On Monday, Prime Medicine Inc (PRME) stock saw a modest uptick, ending the day at $4.39 which represents a slight increase of $0.29 or 7.07% from the prior close of $4.1. The stock opened at $4.23 and ...
Nasdaq4d
Prime Medicine Reports Q3 2024 Financial Progress
Prime Medicine, Inc. ( (PRME)) has released its Q3 earnings. Here is a breakdown of the information Prime Medicine, Inc. presented to its investors. Prime Medicine, Inc. is a biotechnology company ...
Mena FN12d
Prime Medicine To Participate In Upcoming Investor Conferences
(MENAFN- GlobeNewsWire - Nasdaq) CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of ...
manilatimes11d
Prime Medicine to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...
GEN24d
Prime Medicine Spat with Tessera Rumbles on at ESGCT
Then there was a sudden squall in the plenary hall, midway through a session on In vivo Gene Editing in Preclinical Models on Thursday, in which the CSO of Prime Medicine threw shade on the ...